Chronisch mehrfach beeinträchtigte Abhängigkeitskranke" -Überprüfung des Konstrukts CMA im Rahmen der Ambulanten Langzeit-Intensivtherapie für Alkoholkranke (ALITA) [Chronic multimorbid addicts (CMA): evaluation of the construct CMA in the context of the outpatient long-term intensive therapy for alcoholics (OLITA)].
Suchtmedizin in Forschung und Praxis. 2003; 5:221-236.
Therapieprozesse bei ALITA (Ambulante Langzeit-Intensiv-therapie für Alkoholkranke): Multiple Beziehungsgestaltung in der integrativen Therapie chronisch psychisch kranker Menschen [Therapeutic processes in OLITA: multiple development of therapeutic alliance during integrated treatment of chronically mental ill individuals].
Gesprächspsychotherapie und Personzentrierte Beratung. 2003; 34:75-84.
ALITA – Eine Alternative nicht nur für schwerstabhängige, prognostisch benachteiligte Alkoholkranke [OLITA - not only an alternative for severely affected and prognostically handicapped alcoholics].
Abhängigkeiten. 2004; 10(3):78-89.
Substantial decrease of psychiatric comorbidity in chronic alcoholics upon integrated outpatient treatment - results of a prospective study.
J Psychiatr Res.
2004 Nov-Dec;38(6):619-35. doi: 10.1016/j.jpsychires.2004.04.007. PubMed PMID:
15458858.
Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome.
Alcohol Clin Exp Res.
2006 Jan;30(1):86-95. doi: 10.1111/j.1530-0277.2006.00013.x. PubMed PMID:
16433735.
Neuroprotektion: Eine neue Karriere für den hämatopoetischen Wachstumsfaktor Erythropoetin [Neuroprotection: A new career of the hematopoietic growth factor erythropoietin].
Spektrum der Nephrologie. 2006; 19(4):11-21.
Personality disorder and chronicity of addiction as independent outcome predictors in alcoholism treatment.
Psychiatr Serv.
2006 May;57(5):708-12. doi: 10.1176/ps.2006.57.5.708. PubMed PMID:
16675768.
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.
J Pineal Res.
2006 Nov;41(4):313-23. doi: 10.1111/j.1600-079X.2006.00377.x. PubMed PMID:
17014688.
Multimodales Monitoring psychotherapeutischer Prozesse in der Behandlung alkoholkranker Patienten [Multimodal Monitoring of psychotherapeutic processes in the treatment of alcohol dependent patients].
Suchtmedizin in Forschung und Praxis. 2007; 9(1):27-47.
Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence.
Alcohol Alcohol.
2007 Mar-Apr;42(2):92-102. doi: 10.1093/alcalc/agl104. Epub 2006 Dec 18. PubMed PMID:
17179161.
Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis.
Brain.
2007 Oct;130(Pt 10):2577-88. doi: 10.1093/brain/awm203. Epub 2007 Aug 29. PubMed PMID:
17728357.
Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition.
J Ren Nutr.
2008 Jan;18(1):146-53. doi: 10.1053/j.jrn.2007.10.029. PubMed PMID:
18089462.
The influence of personality factors on disease progression and health-related quality of life in people with ALS.
Amyotroph Lateral Scler.
2008 Apr;9(2):99-107. doi: 10.1080/17482960701875805. PubMed PMID:
18428002.
Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor system.
Neuromuscul Disord.
2008 May;18(5):398-407. doi: 10.1016/j.nmd.2008.02.005. Epub 2008 May 5. PubMed PMID:
18456495.
Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches.
Mol Med.
2008 Sep-Oct;14(9-10):546-52. doi: 10.2119/2008-00053.Begemann. PubMed PMID:
18552976; PubMed Central PMCID:
PMC2424319.
Development of an outcome prediction measure for alcoholism therapy by multimodal monitoring of treatment processes.
J Psychiatr Res.
2008 Nov;43(1):30-47. doi: 10.1016/j.jpsychires.2008.01.007. Epub 2008 Mar 14. PubMed PMID:
18342335.
Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.
Ther Adv Neurol Disord.
2008 Nov;1(3):193-206. doi: 10.1177/1756285608098422. PubMed PMID:
21180577; PubMed Central PMCID:
PMC3002551.
Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.
Neurotherapeutics.
2009 Jan;6(1):108-27. doi: 10.1016/j.nurt.2008.10.041. Review. PubMed PMID:
19110203; PubMed Central PMCID:
PMC5084260.
Recombinant human erythropoietin in the treatment of acute ischemic stroke.
Stroke.
2009 Dec;40(12):e647-56. doi: 10.1161/STROKEAHA.109.564872. Epub 2009 Oct 15. PubMed PMID:
19834012.
Response to Letter by Dame.
Stroke. 2010; 41:e167-e168.
Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing.
BMC Neurosci.
2010 Sep 16;11:118. doi: 10.1186/1471-2202-11-118. PubMed PMID:
20846444; PubMed Central PMCID:
PMC2955045.
Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia.
Mol Psychiatry.
2011 Jan;16(1):26-36, 1. doi: 10.1038/mp.2010.51. Epub 2010 May 18. PubMed PMID:
20479759.
Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis.
Acad Radiol.
2013 Sep;20(9):1099-106. doi: 10.1016/j.acra.2013.03.017. Review. PubMed PMID:
23931423; PubMed Central PMCID:
PMC4384461.
Evaluation of an integrated care program for schizophrenia: concept and study design.
Eur Arch Psychiatry Clin Neurosci.
2015 Mar;265(2):155-62. doi: 10.1007/s00406-014-0508-6. Epub 2014 Jun 7. PubMed PMID:
24906973.
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.
Brain.
2016 Feb;139(Pt 2):481-94. doi: 10.1093/brain/awv346. Epub 2015 Dec 8. PubMed PMID:
26647156; PubMed Central PMCID:
PMC4805087.
Prediction and Early Detection of Alzheimer's Dementia: Professional Disclosure Practices and Ethical Attitudes.
J Alzheimers Dis.
2018;62(1):145-155. doi: 10.3233/JAD-170443. PubMed PMID:
29439325.
Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer's Dementia in Individuals With Previous Depression.
Am J Psychiatry.
2018 Mar 1;175(3):232-241. doi: 10.1176/appi.ajp.2017.17040404. Epub 2017 Nov 28. PubMed PMID:
29179578.
Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease.
Brain.
2018 Apr 1;141(4):1186-1200. doi: 10.1093/brain/awy008. PubMed PMID:
29462334; PubMed Central PMCID:
PMC5888938.
How to pursue EPO in MS.
Mult Scler.
2018 Jul;24(8):1139-1140. doi: 10.1177/1352458517733132. Epub 2017 Oct 5. PubMed PMID:
28980507; PubMed Central PMCID:
PMC6029148.
Effectiveness and cost-effectiveness of an integrated care program for schizophrenia: an analysis of routine data.
Eur Arch Psychiatry Clin Neurosci.
2018 Sep;268(6):611-619. doi: 10.1007/s00406-017-0830-x. Epub 2017 Aug 8. PubMed PMID:
28791485.
CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume.
Alzheimers Dement (Amst).
2018;10:782-790. doi: 10.1016/j.dadm.2018.10.003. eCollection 2018. PubMed PMID:
30555890; PubMed Central PMCID:
PMC6280588.
[Quality of life and depression in hearing-impairment : A German survey].
HNO.
2019 Jan;67(1):36-44. doi: 10.1007/s00106-018-0576-4. PubMed PMID:
30324556.
Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer's Disease Spectrum: Association with Amyloid Pathology and Diagnostic Usefulness.
J Alzheimers Dis.
2019;72(2):455-465. doi: 10.3233/JAD-190446. PubMed PMID:
31594223; PubMed Central PMCID:
PMC6918918.
Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study.
Alzheimers Res Ther.
2019 Jul 31;11(1):66. doi: 10.1186/s13195-019-0515-y. PubMed PMID:
31366409; PubMed Central PMCID:
PMC6668160.
Impaired empathy but no theory of mind deficits in adult attention deficit hyperactivity disorder.
Brain Behav.
2019 Oct;9(10):e01401. doi: 10.1002/brb3.1401. Epub 2019 Sep 2. PubMed PMID:
31475781; PubMed Central PMCID:
PMC6790334.
Evaluation of the methoxy-X04 derivative BSC4090 for diagnosis of prodromal and early Alzheimer's disease from bioptic olfactory mucosa.
Eur Arch Psychiatry Clin Neurosci.
2019 Dec;269(8):973-984. doi: 10.1007/s00406-018-0955-6. Epub 2018 Nov 12. PubMed PMID:
30421149.
Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment.
Alzheimers Dement (Amst).
2019 Dec;11:610-618. doi: 10.1016/j.dadm.2019.07.005. eCollection 2019 Dec. PubMed PMID:
31517023; PubMed Central PMCID:
PMC6732671.
Use of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in Germany.
J Alzheimers Dis.
2020;78(3):1137-1148. doi: 10.3233/JAD-200794. PubMed PMID:
33104034.
Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial.
JAMA Netw Open.
2020 May 1;3(5):e206027. doi: 10.1001/jamanetworkopen.2020.6027. PubMed PMID:
32463470; PubMed Central PMCID:
PMC7256670.
Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis.
Front Psychiatry.
2020;11:576. doi: 10.3389/fpsyt.2020.00576. eCollection 2020. PubMed PMID:
32714214; PubMed Central PMCID:
PMC7351505.
To Be Continued? Long-Term Treatment Effects of Antidepressant Drug Classes and Individual Antidepressants on the Risk of Developing Dementia: A German Case-Control Study.
J Clin Psychiatry.
2020 Aug 25;81(5). doi: 10.4088/JCP.19m13205. PubMed PMID:
32857931.
Minor neuropsychological deficits in patients with subjective cognitive decline.
Neurology.
2020 Sep 1;95(9):e1134-e1143. doi: 10.1212/WNL.0000000000010142. Epub 2020 Jul 7. PubMed PMID:
32636322.
Corrigendum: Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis.
Front Psychiatry.
2020;11:589466. doi: 10.3389/fpsyt.2020.589466. eCollection 2020. PubMed PMID:
33061928; PubMed Central PMCID:
PMC7518287.
Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE study.
Alzheimers Res Ther.
2020 Oct 16;12(1):131. doi: 10.1186/s13195-020-00701-7. PubMed PMID:
33066827; PubMed Central PMCID:
PMC7566134.
Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer's disease spectrum.
Neuroimage Clin.
2021;29:102533. doi: 10.1016/j.nicl.2020.102533. Epub 2020 Dec 17. PubMed PMID:
33360018; PubMed Central PMCID:
PMC7770965.
The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease.
Mol Psychiatry.
2021 Feb;26(2):614-628. doi: 10.1038/s41380-019-0404-6. Epub 2019 Mar 21. PubMed PMID:
30899092; PubMed Central PMCID:
PMC6754794.
Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive Decline.
Front Aging Neurosci.
2021;13:626974. doi: 10.3389/fnagi.2021.626974. eCollection 2021. PubMed PMID:
33967736; PubMed Central PMCID:
PMC8097178.
Dental Care of Patients With Dementia: A Survey on Practice Equipment, Training, and Dental Treatment.
Front Oral Health.
2021;2:682139. doi: 10.3389/froh.2021.682139. eCollection 2021. PubMed PMID:
35048026; PubMed Central PMCID:
PMC8757740.
Case Report: Anti-flotillin 1/2 Autoantibody-Associated Atypical Dementia.
Front Psychiatry.
2021;12:626121. doi: 10.3389/fpsyt.2021.626121. eCollection 2021. PubMed PMID:
34211409; PubMed Central PMCID:
PMC8239148.
Mild Cognitive Impairment in Chronic Brain Injury Associated with Serum Anti-AP3B2 Autoantibodies: Report and Literature Review.
Brain Sci.
2021 Sep 14;11(9). doi: 10.3390/brainsci11091208. PubMed PMID:
34573230; PubMed Central PMCID:
PMC8471279.
What would you like to do?